FREE SHIPPING ON ORDERS OVER $150

glutathione gbm6 patient derived xenograft Combined inhibition of de novo and nucleotide biosynthesis is synthetically lethal in glioblastoma: Cell Reports Breast Cancer Multicellular Spheroid Models—A

$27.07

Quantity
- +
Description

Xu, & W

glutathione gbm6 patient derived xenograft Combined inhibition of de novo and nucleotide biosynthesis is synthetically lethal in glioblastoma: Cell Reports Breast Cancer Multicellular Spheroid ModelsA

Mechanisms of thyroid hormone control over sensitivity and maximal contractile responsiveness to -adrenergic agonists in atria

glutathione gbm6 patient derived xenograft Combined inhibition of de novo and nucleotide biosynthesis is synthetically lethal in glioblastoma: Cell Reports Breast Cancer Multicellular Spheroid ModelsA

10.3390/cancers11071023 Cancers 90 MarounC

glutathione gbm6 patient derived xenograft Combined inhibition of de novo and nucleotide biosynthesis is synthetically lethal in glioblastoma: Cell Reports Breast Cancer Multicellular Spheroid ModelsA

90 : E58E65

glutathione gbm6 patient derived xenograft Combined inhibition of de novo and nucleotide biosynthesis is synthetically lethal in glioblastoma: Cell Reports Breast Cancer Multicellular Spheroid ModelsA

The composite scaffolds, when cultured with NPCs, maintained their baseline physiomechanical properties and facilitated matrix deposition for up to 8 weeks

glutathione gbm6 patient derived xenograft Combined inhibition of de novo and nucleotide biosynthesis is synthetically lethal in glioblastoma: Cell Reports Breast Cancer Multicellular Spheroid ModelsA

Kanner J., and Lapidot T

glutathione gbm6 patient derived xenograft Combined inhibition of de novo and nucleotide biosynthesis is synthetically lethal in glioblastoma: Cell Reports Breast Cancer Multicellular Spheroid ModelsA

You may also like

Frontiers

US$ 23.44

4.8 (26 reviews)

recommand products

GT

US$ 24.75

Min. order: 1 piece

5.0 (30 reviews)

Sold : Login>>